Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28554683 | 0.94 | ALDH1A1 (0.50) | SIGMAR1HTR2CALDH1A1NPC1MAPK1 | |
| Ethylene SCHEMBL28319407 | 0.94 | SIGMAR1 (0.48) | SIGMAR1HTR2CALDH1A1PKMNOTUM | |
| SCHEMBL9988136 | 0.85 | SIGMAR1 (0.50) | SIGMAR1HTR2CALDH1A1PKMDRD2 | |
| SCHEMBL9988138 | 0.85 | SIGMAR1 (0.50) | SIGMAR1HTR2CALDH1A1PKMDRD2 | |
| SCHEMBL15510871 | 0.82 | SIGMAR1 (0.43) | SIGMAR1HTR2CALDH1A1PKMDRD2 | |
| SCHEMBL11590574 | 0.82 | SIGMAR1 (0.43) | SIGMAR1HTR2CALDH1A1PKMDRD2 | |
| SCHEMBL1588450 | 0.82 | SIGMAR1 (0.43) | SIGMAR1HTR2CALDH1A1PKMDRD2 | |
| SCHEMBL15510873 | 0.82 | SIGMAR1 (0.43) | SIGMAR1HTR2CALDH1A1PKMDRD2 | |
| SCHEMBL28554684 | 0.82 | PTGS2 (0.45) | SIGMAR1HTR2CALDH1A1MAPK1 | |
| SCHEMBL360448 | 0.80 | ACMSD (0.47) | SIGMAR1HTR2CALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240079271-A1 | WAFER REWIRING DOUBLE VERIFICATION STRUCTURE, AND MANUFACTURING METHOD AND VERIFICATION METHOD THEREOF | CHIPMORE TECHNOLOGY CORPORATION LIMITED (CN) | 2024-03-07 | — | — | US | claimed |
| EP-4017225-A1 | EMBEDDED CIRCUIT BOARD AND PREPARATION METHOD THEREFOR | Shennan Circuits Co., Ltd. (CN) | 2022-06-22 | — | — | EP | claimed |
| US-20220015236-A1 | EMBEDDED CIRCUIT BOARD AND METHOD FOR MANUFACTURING THE SAME | Shennan Circuits Co., Ltd. (CN) | 2022-01-13 | — | — | US | claimed |
| CN-108760936-A | The detection method of Xiao Disorder pill GC finger-prints | 雷允上药业集团有限公司 | 2018-11-06 | — | — | CN | claimed |
| CN-104759292-B | Organic molecule cage supported catalyst and its preparation method and use | 华东师范大学 | 2017-09-19 | — | — | CN | claimed |
| US-7691740-B2 | Semiconductor device and method of fabricating same | KABUSHIKI KAISHA TOSHIBA (JP) | 2010-04-06 | — | — | US | claimed |
| US-20090042358-A1 | SEMICONDUCTOR DEVICE AND METHOD OF FABRICATING SAME | KABUSHIKI KAISHA TOSHIBA | 2009-02-12 | — | — | US | claimed |
| US-6165899-A | Method for manufacturing semiconductor devices having dual damascene structure | NEC CORPORATION (JP) | 2000-12-26 | — | — | US | claimed |
| EP-0031708-B1 | CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR | ICI PHARMA (FR) | 1984-06-13 | — | — | EP | claimed |
| EP-0075434-A2 | Cephalosporins, their preparation and their pharmaceutical compositions | ICI PHARMA (FR) | 1983-03-30 | — | — | EP | claimed |
| EP-0071370-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | ICI PHARMA (FR) | 1983-02-09 | — | — | EP | claimed |
| EP-0031708-A2 | Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor | ICI PHARMA (FR) | 1981-07-08 | — | — | EP | claimed |
| JP-56077300-A | — | — | None | — | — | JP | disclosed |
| JP-11238737-A | — | — | None | — | — | JP | disclosed |
| US-20260130241-A1 | PACKAGE STRUCTURE AND MANUFACTURING METHOD THEREOF | POWERTECH TECHNOLOGY INC. (TW) | 2026-05-07 | — | — | US | disclosed |
| US-20250354092-A1 | CLEANING COMPOSITION AND METHOD FOR REMOVING POLYMER FILM BONDING MATERIALS USING THE SAME | HONGYUE ADVANCED TECH CO LTD (TW) | 2025-11-20 | — | — | US | disclosed |
| EP-0072560-A2 | Process for preparing organic tertiary polyphosphine monooxides | UNION CARBIDE CORPORATION (US) | 1983-02-23 | — | — | EP | disclosed |
| EP-0071370-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | ICI PHARMA (FR) | 1983-02-09 | — | — | EP | disclosed |
| EP-0031708-A2 | Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor | ICI PHARMA (FR) | 1981-07-08 | — | — | EP | disclosed |
| JP-S5677300-A | PREPARATION OF STEROID COMPOUND | SENDAI FUKUSOKAN KAGAKU KENKYUSHO | 1981-06-25 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260130241-A1 | PACKAGE STRUCTURE AND MANUFACTURING METHOD THEREOF | CAD, DSP, EPHA4 | SIGMAR1 2390/4885HTR2C 4276/4885ALDH1A1 1226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.